Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gregory Elliott

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|February 26, 2003
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker, Samuel Z Goldhaber, Ellie Danielson, et al.
Chest|October 19, 2013
EIF2AK4 mutations in pulmonary capillary hemangiomatosisD Hunter Best, Kelli L Sumner, Eric D Austin, et al.
The American Journal of Medicine|November 27, 2012
Adherence to PIOPED II investigators' recommendations for computed tomography pulmonary angiographyDaniel M Adams, Scott M Stevens, Scott C Woller, et al.
ERJ Open Research|July 29, 2025
Rare variants in <i>STAB2</i> in patients with chronic thromboembolic pulmonary hypertensionMark W Dodson, Kristina Allen-Brady, Jeffrey Stevens, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2006
Genetic association of the serotonin transporter in pulmonary arterial hypertensionRajiv D Machado, Rolf Koehler, Eric Glissmeyer, et al.
The American Journal of Medicine|March 21, 2013
Randomized trial of physician alerts for thromboprophylaxis after dischargeGregory Piazza, Frederick A Anderson, Thomas L Ortel, et al.
Human Mutation|September 22, 2015
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic DefectsRajiv D Machado, Laura Southgate, Christina A Eichstaedt, et al.
Human Mutation|January 24, 2006
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertensionRajiv D Machado, Micheala A Aldred, Victoria James, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2018
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary HypertensionIvana Nikolic, Lai-Ming Yung, Peiran Yang, et al.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|February 26, 2003
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker, Samuel Z Goldhaber, Ellie Danielson, et al.
Chest|October 19, 2013
EIF2AK4 mutations in pulmonary capillary hemangiomatosisD Hunter Best, Kelli L Sumner, Eric D Austin, et al.
The American Journal of Medicine|November 27, 2012
Adherence to PIOPED II investigators' recommendations for computed tomography pulmonary angiographyDaniel M Adams, Scott M Stevens, Scott C Woller, et al.
ERJ Open Research|July 29, 2025
Rare variants in <i>STAB2</i> in patients with chronic thromboembolic pulmonary hypertensionMark W Dodson, Kristina Allen-Brady, Jeffrey Stevens, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2006
Genetic association of the serotonin transporter in pulmonary arterial hypertensionRajiv D Machado, Rolf Koehler, Eric Glissmeyer, et al.
The American Journal of Medicine|March 21, 2013
Randomized trial of physician alerts for thromboprophylaxis after dischargeGregory Piazza, Frederick A Anderson, Thomas L Ortel, et al.
Human Mutation|September 22, 2015
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic DefectsRajiv D Machado, Laura Southgate, Christina A Eichstaedt, et al.
Human Mutation|January 24, 2006
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertensionRajiv D Machado, Micheala A Aldred, Victoria James, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2018
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary HypertensionIvana Nikolic, Lai-Ming Yung, Peiran Yang, et al.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
Pageof 12